Logo image of VINE

FRESH VINE WINE INC (VINE) Stock Fundamental Analysis

NYSEARCA:VINE - NYSE Arca - US35804X1019 - Common Stock - Currency: USD

0.575  +0.06 (+12.06%)

After market: 0.58 +0.01 (+0.87%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to VINE. VINE was compared to 32 industry peers in the Beverages industry. VINE has a bad profitability rating. Also its financial health evaluation is rather negative. VINE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

VINE had negative earnings in the past year.
In the past year VINE has reported a negative cash flow from operations.
In the past 5 years VINE always reported negative net income.
VINE had negative operating cash flow in 4 of the past 5 years.
VINE Yearly Net Income VS EBIT VS OCF VS FCFVINE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -5M -10M -15M

1.2 Ratios

VINE's Return On Assets of -469.28% is on the low side compared to the rest of the industry. VINE is outperformed by 90.00% of its industry peers.
Industry RankSector Rank
ROA -469.28%
ROE N/A
ROIC N/A
ROA(3y)-331.96%
ROA(5y)-462.26%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VINE Yearly ROA, ROE, ROICVINE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 500 -500 1K 1.5K

1.3 Margins

VINE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VINE Yearly Profit, Operating, Gross MarginsVINE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -200 -400

More info and screens

0

2. Health

2.1 Basic Checks

VINE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VINE has more shares outstanding
There is no outstanding debt for VINE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VINE Yearly Shares OutstandingVINE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 5M 10M 15M
VINE Yearly Total Debt VS Total AssetsVINE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -57.66, we must say that VINE is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of VINE (-57.66) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -57.66
ROIC/WACCN/A
WACC8.91%
VINE Yearly LT Debt VS Equity VS FCFVINE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 10M -10M

2.3 Liquidity

A Current Ratio of 0.14 indicates that VINE may have some problems paying its short term obligations.
VINE has a Current ratio of 0.14. This is amonst the worse of the industry: VINE underperforms 86.67% of its industry peers.
A Quick Ratio of 0.07 indicates that VINE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.07, VINE is doing worse than 86.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.07
VINE Yearly Current Assets VS Current LiabilitesVINE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.18% over the past year.
VINE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -75.65%.
Measured over the past years, VINE shows a very strong growth in Revenue. The Revenue has been growing by 103.37% on average per year.
EPS 1Y (TTM)66.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.82%
Revenue 1Y (TTM)-75.65%
Revenue growth 3Y103.37%
Revenue growth 5YN/A
Sales Q2Q%-92.55%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VINE Yearly Revenue VS EstimatesVINE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VINE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VINE Price Earnings VS Forward Price EarningsVINE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VINE Per share dataVINE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VINE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FRESH VINE WINE INC

NYSEARCA:VINE (3/21/2025, 8:04:00 PM)

After market: 0.58 +0.01 (+0.87%)

0.575

+0.06 (+12.06%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-14 2022-11-14/amc
Earnings (Next)N/A N/A
Inst Owners2.77%
Inst Owner Change-42%
Ins Owners31.99%
Ins Owner Change0%
Market Cap9.61M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 20.11
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.03
BVpS-0.14
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -469.28%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-331.96%
ROA(5y)-462.26%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.14
Quick Ratio 0.07
Altman-Z -57.66
F-Score3
WACC8.91%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-75.65%
Revenue growth 3Y103.37%
Revenue growth 5YN/A
Sales Q2Q%-92.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y90.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y90.21%
OCF growth 3YN/A
OCF growth 5YN/A